Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Plos One
|
February 7, 2015
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India
Neeraj Raizada, Kuldeep Singh Sachdeva, Achuthan Sreenivas, et al.
Plos One
|
September 8, 2017
Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
Sunil Khaparde, Neeraj Raizada, Sreenivas Achuthan Nair, et al.
International Journal of Mycobacteriology
|
December 4, 2019
Insights in tuberculosis immunology: Role of NKT and T regulatory cells
Pooja Pandey, Anuj Kumar Bhatnagar, Anant Mohan, et al.
Tropical Medicine and Infectious Disease
|
January 22, 2024
Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges
Palak Mahajan, Kathirvel Soundappan, Neeta Singla, et al.
Plos One
|
February 27, 2016
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
Sreenivas Achuthan Nair, Neeraj Raizada, Kuldeep Singh Sachdeva, et al.
Plos One
|
August 25, 2015
Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India
Rajesh D Deshmukh, D J Dhande, Kuldeep Singh Sachdeva, et al.
BMC Health Services Research
|
August 7, 2024
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program
Christina Mergenthaler, Aarushi Bhatnagar, Di Dong, et al.
Plos One
|
July 2, 2015
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis
Kuldeep Singh Sachdeva, Neeraj Raizada, Radhey Shyam Gupta, et al.
Plos One
|
November 11, 2011
Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India
Sarabjit S Chadha, B N Sharath, Kishore Reddy, et al.
Plos One
|
August 5, 2011
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010
Kuldeep Singh Sachdeva, Srinath Satyanarayana, Puneet Kumar Dewan, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Plos One
|
February 7, 2015
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India
Neeraj Raizada, Kuldeep Singh Sachdeva, Achuthan Sreenivas, et al.
Plos One
|
September 8, 2017
Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
Sunil Khaparde, Neeraj Raizada, Sreenivas Achuthan Nair, et al.
International Journal of Mycobacteriology
|
December 4, 2019
Insights in tuberculosis immunology: Role of NKT and T regulatory cells
Pooja Pandey, Anuj Kumar Bhatnagar, Anant Mohan, et al.
Tropical Medicine and Infectious Disease
|
January 22, 2024
Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges
Palak Mahajan, Kathirvel Soundappan, Neeta Singla, et al.
Plos One
|
February 27, 2016
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
Sreenivas Achuthan Nair, Neeraj Raizada, Kuldeep Singh Sachdeva, et al.
Plos One
|
August 25, 2015
Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India
Rajesh D Deshmukh, D J Dhande, Kuldeep Singh Sachdeva, et al.
BMC Health Services Research
|
August 7, 2024
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program
Christina Mergenthaler, Aarushi Bhatnagar, Di Dong, et al.
Plos One
|
July 2, 2015
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis
Kuldeep Singh Sachdeva, Neeraj Raizada, Radhey Shyam Gupta, et al.
Plos One
|
November 11, 2011
Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India
Sarabjit S Chadha, B N Sharath, Kishore Reddy, et al.
Plos One
|
August 5, 2011
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010
Kuldeep Singh Sachdeva, Srinath Satyanarayana, Puneet Kumar Dewan, et al.
Page
of 5